An important activity of HeSMO over the past few years is the support and conduct of observational null clinical studies to collect and process data for the creation of scientific databases for various types of cancer. Thus, the processing of data resulting from the control and recording of results helps to gather important information on the prevalence of neoplastic diseases and the treatment of cancer patients in Greece.

Since May 2013, HeSMO has been linked to ENETS (European Neuroendocrine Tumor Society, to provide data from our country's NET into the European database.

On the other hand, at a time when the National Health System is being tested and stressed, not only financially but also fundamentally, HeSMO, in the context of its social role and with the assistance of collaborating pharmaceutical companies, seeks to ensure the necessary funding for the financial coverage of high cost genetic testing for cancer patients in Greece.